Processa Pharmaceuticals, Inc. — Director's Dealing 2025

Feb 18, 2025

SEC Form 4/A — Form 4/A

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-01-27

Reporting Person: Young David (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-29	Warrants	$0.65	A	124500	Acquired	2030-01-29	Common Stock (124500)	Direct
2025-01-29	Warrants	$0.65	A	62250	Acquired	2030-01-29	Common Stock (62250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	205405	Direct
Common Stock	30985	Indirect
Common Stock	10786	Indirect
Common Stock	18544	Indirect